GPRC5A and triple-negative breast carcinoma: GPRC5A was found to be downregulated in triple-negative breast cancer (TNBC), and its overexpression induced cell apoptosis by regulating the PI3K/Akt signaling pathway, suggesting that GPRC5A serves as a protective factor against TNBC progression by enhancing apoptosis (27)..